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Abstract
Mammalian nuclear receptors broadly influence metabolic fitness and serve as popular targets for developing drugs to treat
cardiovascular disease, obesity, and diabetes. However, the molecular mechanisms and regulatory pathways that govern
lipid metabolism remain poorly understood. We previously found that the Caenorhabditis elegans nuclear hormone receptor
NHR-49 regulates multiple genes in the fatty acid beta-oxidation and desaturation pathways. Here, we identify additional
NHR-49 targets that include sphingolipid processing and lipid remodeling genes. We show that NHR-49 regulates distinct
subsets of its target genes by partnering with at least two other distinct nuclear receptors. Gene expression profiles suggest
that NHR-49 partners with NHR-66 to regulate sphingolipid and lipid remodeling genes and with NHR-80 to regulate genes
involved in fatty acid desaturation. In addition, although we did not detect a direct physical interaction between NHR-49
and NHR-13, we demonstrate that NHR-13 also regulates genes involved in the desaturase pathway. Consistent with this,
gene knockouts of these receptors display a host of phenotypes that reflect their gene expression profile. Our data suggest
that NHR-80 and NHR-13’s modulation of NHR-49 regulated fatty acid desaturase genes contribute to the shortened lifespan
phenotype of nhr-49 deletion mutant animals. In addition, we observed that nhr-49 animals had significantly altered
mitochondrial morphology and function, and that distinct aspects of this phenotype can be ascribed to defects in NHR-66–
and NHR-80–mediated activities. Identification of NHR-49’s binding partners facilitates a fine-scale dissection of its myriad
regulatory roles in C. elegans. Our findings also provide further insights into the functions of the mammalian lipid-sensing
nuclear receptors HNF4a and PPARa.
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Introduction
Modern day lifestyle and diet dramatically increase the threat of
chronic diseases including obesity, diabetes and atherosclerosis.
These metabolic disorders have been consistently linked to the
imbalance between energy consumption and expenditure. Growing
evidence suggests that faulty regulation of fat metabolism promotes
metabolic diseases [1]. The control of fat metabolism is often
mediated by nuclear receptors (NR), which are ligand-regulated
transcription factors that play a central role in the cell’s ability to
sense, transduce and respond to lipophilic signals by modulating the
appropriate target genes [2]. Dissecting the role of nuclear receptors
in fat metabolism is therefore essential to our understanding of how
energy homeostasis is maintained in an organism.
Nuclear receptors typically exhibit highly conserved modular
domains including a zinc-finger DNA binding domain (DBD) and a
ligand-binding domain (LBD) [2]. Ligand binding affects nuclear
receptor activity by inducing structural changes within the LBD,
which then alters the receptor’s affinity to different co-factor
proteins such as co-regulators and binding partner(s). Co-regulators
include both co-activators and co-repressors, and are critical in
mediating transcriptional responses. Alteration in co-regulator–NR
binding can thus lead to a change in the transcriptional response.
For instance, co-repressors can be replaced with co-activators to
promote transcription of target genes, or NRs can form distinct
homo- or heterodimers to activate or repress a specific set of target
genes [3]. Thus, binding of distinct co-factors determines how
nuclear receptors influence different gene networks.
The Hepatocyte Nuclear Factor 4- alpha (HNF4a)i sa n
example of a lipid sensing nuclear receptor in mammals. HNF4a
orchestrates the regulation of a diverse range of target genes and is
especially important in the control of genes involved in glucose and
fatty acid homeostasis [4], and is mainly expressed in the liver,
pancreas, kidney and small intestine [5]. Consistent with its role in
metabolism, mutations in HNF4a are associated with both
maturity onset diabetes of the young (MODY) and type 2 diabetes
[6–9]. Although it is not entirely clear how HNF4a protects
against diabetes, it has been reported that mutations in HNF4a
can lead to early death of pancreatic beta-cells resulting in
pancreatic dysfunction and a subsequent decrease in insulin
PLoS Genetics | www.plosgenetics.org 1 April 2012 | Volume 8 | Issue 4 | e1002645production [10,11]. In addition, knock-out of HNF4a in the adult
mouse liver leads to increased lipid accumulation in hepatocytes
and to the misregulation of genes involved in glucose and lipid
metabolism [12,13].
HNF4 receptors are evolutionarily conserved. Whereas mam-
mals have two paralogs of this receptor, HNF4a and HNF4c, the
HNF4 family has expanded enormously in the nematode C. elegans
to include 269 HNF4-like members [14,15]. One of these 269
HNF4-like members is NHR-49, which is remarkably similar to
the mammalian Peroxisome Proliferator-Activated Receptors
(PPARs) in its overall biological effects on metabolism, fat storage,
and life span [16]. The PPARs are global modulators of fat
metabolism, controlling fat storage, expenditure, distribution and
transport [17]. Perhaps most striking is the finding that NHR-49
and the PPARs, particularly PPARa and PPARd, positively
influence similar genes in multiple metabolic processes, including
fatty acid b-oxidation, fatty acid desaturation, and fatty acid
binding/transport [17,18]. Moreover, knockout of PPARa or
PPARd can lead to high-fat phenotypes [18,19] that are similar to
those observed in nhr-49 animals, demonstrating the common
physiological effects of these receptors on fat storage.
In this study, we set out to elucidate the genome-wide regulatory
network of NHR-49 and to characterize its target genes to better
understand the impact of NHR-49 mediated transcriptional
regulation on worm physiology. We identified NHR-66 and
NHR-80 as physical NHR-49 co-factors and were able to
delineate their specific contribution to distinct phenotypes of nhr-
49 mutants, namely selective effects of individual co-factors on life
span and on mitochondrial function. We also uncovered novel
roles for NHR-49 in the regulation of lipid metabolism including
sphingolipid breakdown and lipid remodeling. Taken together,
our findings support a model whereby NHR-49 heterodimerizes
with other nuclear receptors to mediate the activation or
repression of genes involved in distinct aspects of lipid metabolism.
Results
NHR-49 activates and represses genes in multiple lipid
metabolism pathways
We previously found that NHR-49 promotes two distinct
aspects of lipid metabolism, fatty acid desaturation and fatty acid
b-oxidation [16]. However, the complete list of NHR-49’s
regulatory targets was still not known. Thus, we used whole
genome C. elegans oligonucleotide microarrays to define the
transcriptional profiles in an nhr-49(nr2041) deletion strain
(compared to N2 wild-type worms). Table 1 lists genes that
exhibit statistically significant changes in expression with (|log2(-
ratio)|$0.848 and p-value#0.001), in nhr-49 animals ([20] and
Materials and Methods). The genes with negative values of logFC
(fold change) are down regulated in the nhr-49 mutant (i.e.
activated by NHR-49), whereas the genes with positive values of
logFC are up regulated in the nhr-49 mutant (repressed by NHR-
49). The finding that acs-2, which participates in mitochondrial b-
oxidation and was previously demonstrated to be an NHR-49
target gene [16] had reduced expression in nhr-49 mutants
validated the experimental approach. However, some of the
previously reported genes like fat-5, fat-6, fat-7, cpt-2 and ech-1[16],
were not found to be significant in our microarray analysis. This is
likely due to the cut-off that we employed. We also uncovered new
targets that are repressed by NHR-49 that include genes involved
in sphingolipid breakdown, lipid remodeling and xenobiotic
detoxification.
To validate these candidate NHR-49 targets, we employed
quantitative RT-PCR to analyze their mRNA levels (Figure 1). In
nhr-49 mutants, the expression of the sphingolipid processing genes
acid ceramidase, glycosyl hydrolase, sphingosine-phosphate lyase
(SPL), as well as lipid remodeling genes like phospholipases, TAG
lipase and O-acyltransferase, was up regulated, as expected
(Figure 1A and Table S1). Consistent with previously published
data, nhr-49 mutants also showed a decrease in the expression of
the fatty acid desaturase genes fat-7, fat-5 and fat-6, and the fatty
acid beta-oxidation genes acs-2, cpt-5 and ech-1 (Figure 1B).
Together, the gene expression data confirm that NHR-49 activates
fatty acid b-oxidation and desaturase genes, and for the first time
identifies target genes repressed by NHR-49 that include those
involved in sphingolipid processing and lipid remodeling.
To identify pathways and molecular functions common to the
genes observed by microarray analysis, we employed the gene
ontology (GO) enrichment analysis using GOrilla [21]. As
expected due to NHR-49’s known role in lipid biology, there
was a significant overrepresentation of GO-terms for functions
related to fat metabolism (Figure 2 and Table 2). We also found
that pathways regulating protein processing, maturation and
proteolysis were overrepresented.
Identification of candidate NHR-49 co-factors
Because NRs form homo and/or heterodimers and associate
with co-regulators, we hypothesized that NHR-49 might differen-
tially regulate its distinct target genes by interacting with specific
transcriptional co-factors [22]. To identify such factors, we
performed a yeast two-hybrid screen using the NHR-49-LBD as
bait. In addition to the Mediator subunit MDT-15 [23], we
identified six NHRs as candidate NHR-49-LBD partners (Table
S2a). Notably, all NHR prey clones identified included their
respective LBDs, suggesting that dimerization occurs via the LBD,
as has been described for other NRs. We estimated the relative
binding strength of these preys using a LacZ reporter, and found
that five of the six NHRs interacted strongly and specifically with
the NHR-49 LBD (Table S2b). In parallel, a large-scale yeast-two-
hybrid screen identified a set of 13 additional candidates to
interact with full-length NHR-49 (Table S2a) [24]. Because they
were identified in both yeast-two-hybrid screens, we deemed
NHR-13, MDT-15, NHR-22, NHR-66, and NHR-105 as most
likely to represent NHR-49 cofactors.
Author Summary
Mammalian nuclear receptors are actively targeted for
treatment of a range of cardiovascular diseases and
obesity. However, effective drug development still de-
pends on a more exhaustive characterization of how
different nuclear receptors mediate their different physi-
ological effects in vivo. Taking advantage of the round-
worm Caenorhabditis elegans, we used a combination of
genetic and biochemical approaches to characterize the
gene network of the nuclear receptor NHR-49 and to
explore the impact of the different target genes on
physiology. This work has identified genes and pathways
that were not previously known to be regulated by NHR-
49. Importantly, we identified NHR-49 co-factors NHR-66
and NHR-80 that regulate specific subsets of NHR-49 target
genes and that contribute to distinct phenotypes of nhr-49
animals. Taken together, our findings in C. elegans not only
provide novel insights into how nuclear receptor tran-
scriptional networks coordinate to regulate lipid metabo-
lism, but also reveal the breadth of their influence on
different aspects of animal physiology.
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ID Name logFC AveExpr P.Value Gene WB ID Gene Public Name
cea2.p.158395 F45D11.1 2.36 8.5 3.84E-05 WBGene00018448 F45D11.1
cea2.i.07091 Y71F9B.6 1.18 6.75 0.000976 WBGene00022128 Y71F9B.6
cea2.i.11595 F27E5.1 2.55 8.52 2.90E-05 WBGene00009192 F27E5.1
cea2.p.110908 C45B11.3 22.83 7.56 0.000249 WBGene00000981 dhs-18
cea2.i.31736 ZK617.2 2.33 11.1 8.42E-05 WBGene00014009 lips-6
cea2.3.07963 E02H9.5 2.41 6.7 1.94E-05 WBGene00017103 E02H9.5
cea2.i.08369 B0454.8 1.75 7.7 0.000706 WBGene00015199 B0454.8
cea2.i.31956 B0222.4 4.12 6.42 6.03E-05 WBGene00006418 tag-38
cea2.d.10890 C05E4.9b 21.57 11.4 0.000505 NA NA
cea2.i.48948 ZK218.5 2.35 9.57 5.54E-05 WBGene00013939 ZK218.5
cea2.p.110949 C47A10.1 2.07 8.23 5.08E-05 WBGene00004003 pgp-9
cea2.i.07568 ZK265.1 21.33 8.32 0.00053 WBGene00013955 kri-1
cea2.i.32048 B0348.2 4.36 8.64 2.67E-06 WBGene00015152 B0348.2
cea2.p.48441 W02B12.1 1.61 9.77 0.000192 WBGene00012201 W02B12.1
cea2.c.41613 C18A11.1 1.78 8.19 0.000508 WBGene00015947 C18A11.1
cea2.d.33151 K09H11.7 21.52 11.2 0.000274 WBGene00019604 K09H11.7
cea2.c.35812 F28F8.2 24.44 8.05 9.88E-07 WBGene00009221 acs-2
cea2.d.21244 F18E3.7a 21.48 7.09 0.000358 NA NA
cea2.p.120260 K01D12.11 1.52 10.5 0.000667 WBGene00010470 cdr-4
cea2.i.30276 Y46C8AL.3 1.56 6.73 0.00046 WBGene00021581 clec-70
cea2.p.47717 T24E12.5 2.53 6.62 0.000225 WBGene00020774 T24E12.5
cea2.p.87235 C32H11.12 21.73 7.33 0.000163 WBGene00007875 dod-24
cea2.c.15603 Y57A10C.6 21.3 10.2 0.000595 WBGene00013284 Y57A10C.6
cea2.p.114229 F21F8.4 1.54 9.94 0.000793 WBGene00017678 F21F8.4
cea2.d.21251 F18E3.7a 21.89 8.97 8.26E-05 NA NA
cea2.i.33937 C29F3.5 2.74 7.36 0.000224 WBGene00007806 clec-230
cea2.p.47251 T19D12.4 1.92 7.68 0.000372 WBGene00020579 T19D12.4
cea2.d.21252 F18E3.7a 22 9.62 5.71E-05 NA NA
cea2.i.46562 Y37H2A.11 2.69 9.5 0.000213 WBGene00012571 Y37H2A.11
cea2.p.21595 Y47H10A.5 1.59 9.24 0.000476 WBGene00012961 Y47H10A.5
cea2.p.40219 F49E12.9 1.61 8.34 0.000365 WBGene00009902 F49E12.9
cea2.i.44641 T16G1.6 1.91 7.4 0.000298 WBGene00011800 T16G1.6
cea2.p.39387 F43C11.7 1.35 7.14 0.000667 WBGene00018384 F43C11.7
cea2.d.24252 F37B1.3 1.86 7.32 0.000357 WBGene00001762 gst-14
cea2.c.32957 ZK550.6 21.3 9.65 0.000807 WBGene00014000 ZK550.6
cea2.i.15206 T10B9.1 2.1 7.82 5.66E-05 WBGene00011671 cyp-13A4
cea2.i.46998 Y40B10A.2 1.4 8.39 0.000517 WBGene00021487 Y40B10A.2
cea2.i.38305 F35E8.8 1.92 7.36 0.000136 WBGene00001786 gst-38
cea2.i.35082 C53A3.2 21.58 8.31 0.000314 WBGene00016892 C53A3.2
cea2.i.24912 C54E4.5 1.47 8.8 0.000379 WBGene00016920 C54E4.5
cea2.i.34217 C36C5.14 2.15 7.07 6.50E-05 WBGene00016483 C36C5.14
cea2.p.110129 C29F3.2 2.28 7.58 6.65E-05 WBGene00006954 wrt-8
cea2.c.38150 T05B4.3 21.33 11.1 0.000641 WBGene00020237 phat-4
cea2.p.117903 F53E10.4 1.54 7.15 0.000519 WBGene00018760 F53E10.4
cea2.d.42799 Y19D10A.9 22.02 7.77 0.000151 WBGene00021224 clec-209
cea2.i.06720 Y65B4BR.1 2.78 10.1 0.000136 WBGene00022040 Y65B4BR.1
cea2.c.37571 K12G11.3 22.63 9.5 4.30E-05 WBGene00010790 sodh-1
doi:10.1371/journal.pgen.1002645.t001
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PLoS Genetics | www.plosgenetics.org 3 April 2012 | Volume 8 | Issue 4 | e1002645Figure 1. NHR-49 collaborates with NHR-66 to regulate sphingolipid and lipid remodeling genes and with NHR-80 and NHR-13 to
regulate fatty acid desaturase genes. (A) qRT-PCR measurement of genes involved in sphingolipid metabolism including fatty acid ceramidase,
sphingosine phosphate lyase, glycosyl hydrolase and genes involved in lipid remodeling namely phospholipases, TAG lipase and O-acyltransferease
expression in nhr-49(nr2041) (blue bars), nhr-66(ok940) (pink bars), nhr-80(tm1011) (green bars) and nhr-13(gk796) (purple bars) relative to wild-type
animals. Values represent overall fold change of nhr-49(nr2041), nhr-66(ok940), nhr-80(tm1011) and nhr-13(gk796) animals with respect to wild-type
worms. Expression was measured in L4 stage of development. Error bars represent SEM from 3 independent experiments. (B) qRT-PCR measurement
of genes involved in fatty acid desaturases including fat-5, fat-6 and fat-7 and genes involved in fatty acid beta-oxidation including acs-2, cpt-5 and
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To determine whether any of these cofactors regulate the newly
identified NHR-49 pathways of sphingolipid processing, lipid
remodeling or the b-oxidation and fatty acid desaturation
pathways, we quantified the mRNA levels of the NHR-49
activated and repressed genes in these pathways (see primer pairs,
Tables S3 and S4). We chose to analyze the nhr-13(gk796) and nhr-
66(ok940) mutants, and also included nhr-80(tm1011) because it
regulates the fatty acid desaturase genes [25]. Our qRT-PCR
analyses revealed a striking separation of gene regulation by the
different candidate co-factors. The deletion of nhr-66(ok940)
resulted in the up regulation of most of the genes that are
repressed by NHR-49, including the sphingolipid and lipid
remodeling genes (Figure 1A and Table S1). The levels of
derepression of these genes observed in nhr-66 mutants were
comparable to that seen in nhr-49 animals, suggesting that the two
NRs act together. In contrast, nhr-66 mutants did not show any
change in the expression of nhr-49 activated genes, like those
involved in b-oxidation and desaturation (Figure 1B and Table
S1). These results strongly suggest that NHR-49 acts with NHR-
66 to specifically repress the transcription of sphingolipid and lipid
remodeling genes.
In contrast, nhr-80 and nhr-13 deletion mutants do not affect the
sphingolipid, lipid remodeling, or b-oxidation genes. Instead, these
mutants exhibited a decreased expression of the fatty acid
desaturase genes fat-7, fat-5 and fat-6 (Figure 1B), confirming
previous analyses of nhr80 mutants by the Watts laboratory [25].
The fat-5, fat-6 and fat-7 genes are members of the D9 fatty acid
desaturases and are key enzymes in fatty acid metabolism [26].
Their function is to introduce a double bond in saturated fatty acid
chains to generate monounsaturated fatty acids (MUFAs) that are
important in membrane fluidity and energy storage [27]. These
results suggest that NHR-49 associates with NHR-80 and NHR-
13 to regulate the ratio of saturated and unsaturated fat in lipid
membranes. However, the fold changes observed in fatty acid
desaturation regulation by NHR-80 and NHR-13 did not parallel
ech-1 in nhr-49(nr2041) (blue bars), nhr-66(ok940) (pink bars), nhr-80(tm1011) (green bars) and nhr-13(gk796) (purple bars) relative to wild-type animals.
Values represent overall fold change in nhr-49(nr2041), nhr-66(ok940), nhr-80(tm1011) and nhr-13(gk796) animals relative to wild-type worms.
Expression was measured at L4 stage of development. Error bars represent SEM from 3 independent experiments.
doi:10.1371/journal.pgen.1002645.g001
Figure 2. Functional classification summary for the nhr-49 mutant are represented as a scatter plot using the GO visualization tool
REViGO. X- and Y-axes represent a two-dimensional annotation space derived from a multi-dimensional scaling procedure used on a matrix of GO
terms’ semantic similarities (see reference 51 for details). By employing this visualization method, similar functional categories will cluster together.
Bubble color represents the p-value obtained from GO term enrichment analysis (GOrilla, see Materials and Methods) and bubble size relates to the
frequency of GO terms in the Gene Ontology Annotation Database.
doi:10.1371/journal.pgen.1002645.g002
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other regulatory factors. Consistent with this, the C. elegans
ortholog of the sterol-regulatory-element-binding protein (SREBP)
transcription factor SBP-1 and the Mediator subunit MDT-15
are also implicated in the regulation of fatty acid desaturases
[23,28–30].
NHR-66 and NHR-80 regulate additional targets
independently of NHR-49
Our data strongly suggest that NHR-66 regulates genes in the
sphingolipid and lipid remodeling pathways whereas NHR-80
regulates the fatty acid desaturase genes. To determine whether
these NRs regulate other genes in addition to these NHR-49
targets, we performed a genome-wide microarray analysis on nhr-
66 and nhr-80 mutants. The list of differentially regulated nhr-66
and nhr-80 genes is presented in tables S5 and S7, respectively, and
the corresponding GO term analyses of NHR-66 and NHR-80 is
presented in Tables S6 and S8, respectively. As expected, the
microarray data confirmed that NHR-66 regulates several genes
involved in the sphingolipid and lipid remodeling pathways, and
that NHR-80 regulates genes involved in fatty acid desaturation.
In addition, Figure 3A and Table S9 show the genes commonly
regulated by NHR-49 & NHR-66 and NHR-49 & NHR-80, using
our microarray analysis. We also found evidence that these nuclear
receptors regulate additional target genes. For example, NHR-66
is involved in GDP-mannose metabolic processes and regulates
gmd-2, a GDP-mannose dehydratase. The NHR-80 GO analysis
indicates that it regulates genes involved in several different
processes including embryonic development and cell death. In
conclusion, our analyses suggest that NHR-66 and -80 are not
only transcriptional partners required for NHR-49, but can
independently act with other binding partners to regulate unique
pathways (Figure 3A).
NHR-49 physically interacts with NHR-66 and NHR-80
Our yeast-two-hybrid and gene expression data suggested that
NHR-49 might directly interact with NHR-66, NHR-80 and
NHR-13. To test this, we performed in vitro GST-NHR-49 pull-
down assays with full-length NHR-66, NHR-80 and NHR-13
proteins. NHR-49 was a positive control since it exhibits a two-
hybrid interaction with itself [24]. Purified glutathione-S-transfer-
ase (GST)-tagged NHR-49 was incubated with in vitro translated
35S-methionine-labeled NHR-49, NHR-66, NHR-80 and NHR-
13. As expected, GST-NHR-49 successfully formed a homodimer
with radiolabeled NHR-49 (Figure 3B). In addition, it was also
able to interact directly with NHR-66 and NHR-80. NHR-13 did
not bind to NHR-49 in vitro above background levels, suggesting
that additional factors may contribute to an interaction with
NHR-49 in vivo. Alternately, NHR-13 may regulate fatty acid
desaturation via another unknown mechanism.
NHR-49’s regulation of fatty acid desaturases contributes
to lifespan
The physical interaction and functional studies support a model
whereby the control of distinct NHR-49 regulatory modules is
based on NHR-49’s association with distinct partner proteins. In
this case, mutation of individual NHR-49 partners should
delineate the contributions of each co-factor to the phenotypes
observed in nhr-49 mutants. For example, knocking out NHR-66
could reveal NHR-49-dependent sphingolipid and lipid remodel-
ing gene mediated phenotypes, whereas knocking out NHR-80
and NHR-13 could reveal NHR-49 dependent fatty acid
desaturase regulated phenotypes. We note that although we did
not obtain clear evidence that NHR-13 is a direct physical partner
of NHR-49, we continued to characterize it because its gene
expression profile suggests it plays a role in fatty acid desaturation.
Among the many phenotypes exhibited by nhr-49 mutants, we
chose to focus on its reduced lifespan. To determine what pathway
of NHR-49 is important in regulating its lifespan, we analyzed the
individual co-factor mutants for effects on lifespan. The nhr-66
mutant animals had a lifespan of 17.16+/20.41 days compared to
wild-type lifespan of 17.35+/20.34 days, suggesting that sphin-
golipid and lipid remodeling genes do not play a role in the
reduced lifespan phenotype of nhr-49 mutants (Figure 4). In
contrast, at 20uC, nhr-80 and nhr-13 mutants had significantly
shorter lifespans of 13.19+/20.38 days and 14.17+/20.4 days,
respectively (Figures 4A and 4B and Table S10). Moreover, an nhr-
80; nhr-13 double mutant had a lifespan of 12.29+/20.37 days,
which approaches the nhr-49 mutant lifespan of 9.52+/20.23
days. Together, these results suggest that the reduced expression of
fatty acid desaturases observed in the nhr-80 and nhr-13 mutants
might contribute to the shortened lifespan of nhr-49 animals.
These observations are in accordance with previously published
work demonstrating that shortened lifespan is correlated with
lowered expression of the fat-7 SCD (Stearoyl CoA Desaturase)
[16]. In addition, both nhr-49 mutants and worms where FAT-7
was knocked down using RNA-interference, exhibit a concomitant
increase in the levels of saturated fat. More specifically, the
Table 2. Occurrence of gene families in microarray results for
NHR-49, based on GO-terms.
GO Term Description P-value
GO:0006629 lipid metabolic process 1.55E-11
GO:0006631 fatty acid metabolic process 1.45E-06
GO:0032787 monocarboxylic acid metabolic process 4.46E-06
GO:0044255 cellular lipid metabolic process 1.34E-05
GO:0055114 oxidation-reduction process 1.72E-05
GO:0016540 protein autoprocessing 3.87E-05
GO:0007367 segment polarity determination 3.87E-05
GO:0007365 periodic partitioning 3.87E-05
GO:0030258 lipid modification 4.28E-05
GO:0008152 metabolic process 1.52E-04
GO:0010332 response to gamma radiation 2.66E-04
GO:0006508 proteolysis 2.87E-04
GO:0016485 protein processing 3.52E-04
GO:0034440 lipid oxidation 3.84E-04
GO:0006635 fatty acid beta-oxidation 3.84E-04
GO:0019395 fatty acid oxidation 3.84E-04
GO:0072329 monocarboxylic acid catabolic process 3.84E-04
GO:0009062 fatty acid catabolic process 3.84E-04
GO:0051604 protein maturation 4.60E-04
GO:0030259 lipid glycosylation 4.91E-04
GO:0043436 oxoacid metabolic process 6.05E-04
GO:0006082 organic acid metabolic process 6.05E-04
GO:0019752 carboxylic acid metabolic process 6.05E-04
GO:0016042 lipid catabolic process 8.12E-04
GO:0044242 cellular lipid catabolic process 8.83E-04
GO:0042180 cellular ketone metabolic process 8.95E-04
doi:10.1371/journal.pgen.1002645.t002
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stearic acid and oleic acid (C18:0/C18:1n9) to approximately
3.74+/20.33 in nhr-49 animals (0.98+/20.06 in wild-type
animals). We thus quantified the abundance of individual fatty
acids species in nhr-13, nhr-80, and nhr-80; nhr-13 mutants using
Gas Chromatography-Mass Spectrometry (GC-MS). The C18:0/
C18:1n9 ratio in nhr-80; nhr-13 double mutants (2.99+/20.22) was
similar to the ratio observed in nhr-49 mutants, and higher than
the ratio in wild-type worms (0.98+/20.06) (Figure 5A and Table
S11). Strikingly, there is a strong inverse correlation (r
2=0.86)
between the level of saturated fat and the duration of mean worm
lifespan (Figure 5B), supporting the notion that excess saturated fat
plays a role in the early death of the nhr mutants. These results also
suggest that NHR-49’s interaction with NHR-80 and possibly
NHR-13 contributes to the shortened lifespan phenotype that is
observed in nhr-49 mutants.
NHR-49 is important for normal mitochondrial
morphology
To understand why the imbalance of lipid saturation observed
in nhr-49 mutants could be detrimental to the animal, we
hypothesized that the excess pool of saturated fat might get
incorporated into membranes, thus affecting their function.
Because NHR-49 functionally resembles the PPAR family of
mammalian nuclear receptors that promote mitochondrial
biogenesis [31,32], we employed high pressure-transmission
electron microscopy (HP-TEM) to visualize mitochondria in nhr-
49 animals (Figure 6). This ultrastructural analysis revealed
multiple morphological defects in the intestinal mitochondria of
one-day old adult nhr-49 mutants (compared to wild-type worms),
although mitochondria in nhr-49 mutants were comparable in size
to wild-type mitochondria (Figure 7A). Strikingly, when we
measured the average fractional area occupied by mitochondria
per total intestinal area in nhr-49 mutants, we found that there was
a considerable variation in the distribution, although the average
was not statistically different from wild-type animals (Figure 7B).
Moreover, about 25% of the intestinal mitochondria of the nhr-49
mutants were uncharacteristically irregular in shape and appeared
to have more turns compared to wild-type animals (Figure 6A).
The average number of turns exhibited by the intestinal
mitochondria in nhr-49 animals was greater than the more
rounded wild-type mitochondria (Figure 7C). Taken together,
these results suggested that mitochondria in nhr-49 animals exhibit
Figure 3. NHR-49 shares target genes and physically interacts with NHR-66 and NHR-80. (A) Venn diagram showing the comparison of
genes regulated by NHR-49, NHR-66 and NHR-80. Gene identities are presented in Table S9. (B) NHR-49 physically interacts with NHR-49, NHR-66 and
NHR-80 in vitro. Pull-down assays showing in vitro translated
35S-methionine labeled NHR-49, NHR-66, NHR-80 and NHR-13 binding purified GST-NHR-
49 fusion protein versus purified GST-alone control. The protein mixtures of
35S-methionine-labeled NHRs were incubated with glutathione-
sepharose 4B beads and analyzed by SDS-PAGE (4–12%) followed by autoradiography. The input represents 0.1% of the labeled proteins used for the
pull down assays.
doi:10.1371/journal.pgen.1002645.g003
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the same age.
Partner co-factors contribute to NHR-49’s regulation of
mitochondrial morphology
We next asked if the NHR-49 partners NHR-66 and NHR-80
contribute to the observed NHR-49 mitochondrial abnormalities.
In contrast to nhr-49 mutants, the mitochondria in one-day old
adult nhr-66 and nhr-80 mutants were comparable in shape to
those observed in wild-type worms (Figure 6B and 7A). However,
the average fractional area occupied by the mitochondria in the
intestine was significantly higher in nhr-66 animals and signifi-
cantly lower in nhr-80 animals (compared to wild-type worms;
Figure 7B). Lastly, even though the average size of the intestinal
mitochondria in the nhr-66 animals was similar to the size of
mitochondria in wild-type animals, the nhr-80 animals showed
significantly smaller mitochondria (Figure 7C).
Because these data suggested that NHR-66 and NHR-80
contribute to mitochondrial morphology, we next examined
intestinal mitochondria in one-day old adult nhr-66; nhr-80 double
mutants. The fractional area of mitochondria in these animals was
not statistically different from wild-type when averaged, but the
distribution was much broader, similar to nhr-49 animals
(Figure 7B). In addition, 11.4% of the intestinal mitochondria in
the double mutants were highly irregular in shape, as was observed
in 25% of the mitochondria in nhr-49 mutants (Figure 6C and
Figure 7C). Although the mitochondrial phenotypes in nhr-66; nhr-
80 mutants are not as strong as those in the nhr-49 animals, these
data do suggest that NHR-66 and NHR-80 contribute to normal
mitochondria morphology. Together, these data suggest that
NHR-49 maintains mitochondrial morphology via multiple
Figure 4. nhr-80; nhr-13 double mutants have a reduced lifespan comparable to that of nhr-49 animals. (A) The percentage of animals
remaining alive is plotted against animal age. Adult lifespan survival curves of WT (black), nhr-49(nr2041) (blue), nhr-66(ok940) (pink), nhr-80(tm1011)
(green), nhr-13(gk796) (purple) and double mutant nhr-80; nhr-13 (brown) animals. (B) The bar graph represents the combined mean (+/2SEM) adult
lifespan (days) from at least four independent experiments.
doi:10.1371/journal.pgen.1002645.g004
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as well as additional, unknown mechanisms.
Impaired mitochondrial morphology affects
physiological function
Because mitochondrial morphology was altered in the nhr
mutants, we assayed mitochondrial function using two metabolic
assays. First, we monitored the basal oxygen consumption rates in
live animals (normalized to worm count). Consistent with the
mitochondrial abnormalities observed by electron microscopy, nhr-
49 animals consumed oxygen at significantly reduced rates of
5.22 pmoles/min/worm compared to 9.625 pmoles/min/worm in
wild-type animals (Figure 8A). The single mutants nhr-66 and nhr-80
also had reduced basal oxygen consumption rates of 6.12 and
7.44 pmoles/min/worm, respectively. Interestingly, the respiration
rate for the nhr-66; nhr-80 double mutant was lower than that of nhr-
49 with a rate of 3.87 pmoles/min/worm but higher than the
electron transport chain (ETC) complex I defective mutant gas-
1(fc21), which showed rates of 2.55 pmoles/min/worm.
In a second assay for mitochondrial function, we indirectly
measured b-oxidation by feeding the animals radiolabeled palmitic
acid and then measuring the rates of production of an acid soluble
metabolites, a byproduct of lipid oxidation. As the mitochondrial
b-oxidation gene acs-2 is down regulated in nhr-49 mutants and
contributes to their increased fat content, we used the acs-
2(ok2457) mutant as a control [16]. Just like the acs-2 mutants, the
nhr-49 animals also had a significant reduction in acid soluble
metabolite production with a rate of 0.56 pmole/min/mg protein
compared to 1.29 observed in wild-type animals (Figure 8B).
Surprisingly, although the qRT-PCR analysis did not predict
NHR-66 and NHR-80 to regulate genes in the b-oxidation
pathway, the nhr-66 and nhr-80 single mutants also exhibited
reduced oxidation rates (0.69 and 0.43 pmole/min/mg protein,
Figure 5. Higher levels of saturated fat in nhr-80;nhr-13 and nhr-49 animals correlate with shortened lifespans. (A) Relative abundance
of individual fatty acid species expressed as percentage of total measured fatty acid. Fatty acids were isolated and quantified by GC/MS from WT
(black bars), nhr-49 (blue bars), nhr-66 (pink bars), nhr-80 (green bars), nhr-13 (purple bars) and nhr-80; nhr-13 (brown) animals. Error bars represent
SEM. (B) Correlation between the ratio of C18:0 to C18:1n9 and mean lifespan.
doi:10.1371/journal.pgen.1002645.g005
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nhr-80 mitochondria differ from wild-type, which may be
explained by the reduced b-oxidation in these mutants. The b-
oxidation rate for the nhr-66; nhr-80 double mutants was also
significantly reduced relative to wild-type animals (0.43 pmole/
min/ug protein), although the rate in the double mutant was
identical to the rate in the single mutant with the stronger effect
(nhr-80), suggesting that the two NRs may act in the same pathway.
Together, our data show that altered mitochondrial morphology
strongly correlates with aberrant mitochondrial physiology, and
they further suggest that several NRs play a significant role in
maintaining normal mitochondrial function.
Discussion
NHR-49 regulates genes involved in fatty acid b-oxidation and
fatty acid desaturation [16], but its full influence on lipid
metabolism remained obscure. Here, we reveal a previously
Figure 6. nhr-49 mutants show abnormal mitochondrial morphology. (A) High pressure freezing transmission electron microscopy (HP-TEM)
images of wild-type animals and nhr-49 mutants at the same magnification. Note that mitochondria are outlined in blue. Bar, 0.5 mm. (B) HP-TEM
images of nhr-66 and nhr-80 mutants at the same magnification. Note that the mitochondria are outlined in blue. Bar, 1.0 mm. (C) Two HP-TEM images
of nhr-66; nhr-80 animals at the same magnification. Note that the mitochondria are outlined in blue. Bar, 1.0 mm.
doi:10.1371/journal.pgen.1002645.g006
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49, nhr-80, nhr-66 and nhr-66; nhr-80 animals. Each point represents the average size of all the intestinal mitochondria examined per section. P-values
were obtained using the unpaired t-test with Welch’s correction for unequal variance. This analysis showed that the difference between nhr-80
animals and wild-type is statistically significant with a p-value,0.0001. (B) Quantification of mitochondrial fractional area in WT, nhr-49, nhr-80, nhr-66
and nhr-66; nhr-80 animals. Each point represents the average fractional area (mm
2) of the examined mitochondria per section. P-values were
obtained using the unpaired t-test with Welch’s correction for unequal variance. This analysis showed that the difference between nhr-66 and nhr-80
animals compared to wild-type was statistically significant with p-values of 0.0440 and 0.0025 respectively. (C) Quantification of mitochondrial shape
in WT, nhr-49, nhr-80, nhr-66 and nhr-66; nhr-80 animals. Each point represents the average number of mitochondrial turns in the section examined. P-
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in the repression of sphingolipid processing and lipid remodeling.
We also identify several NHR-49 interacting partner receptors and
show that at least two of these, NHR-66 and NHR-80 directly
bind to NHR-49 and modulate separable NHR-49 dependent
pathways. In characterizing NHR-49’s transcriptional network
and studying its influence on physiology, our findings inform us on
the evolutionary history of HNF4-related receptors across species
and on their conserved metabolic pathways and physiological
functions.
NHR-49’s transcriptional network
HNF4a plays an important role in mammalian physiology and
despite the identification of several HNF4 bound and regulated
genes, it is still unclear what the relevant targets are in vivo. The
number of genes estimated to be regulated by HNF4a varies
values were obtained using the unpaired t-test with Welch’s correction for unequal variance. This analysis showed that the difference between nhr-
49animals compared to wild-type was statistically significant with a p-value,0.0001.
doi:10.1371/journal.pgen.1002645.g007
Figure 8. nhr-49 animals have reduced basal oxygen consumption rates and reduced beta-oxidation. (A) Basal oxygen consumption
rates of WT, nhr-49, nhr-80, nhr-66, nhr-66; nhr-80 and gas-1 animals. P-values were obtained using the unpaired t-test. *** p,0.001. (B) Evaluating b-
oxidation by measuring amounts of radiolabeled acid-soluble metabolites in WT, nhr-49, nhr-80, nhr-66, nhr-66; nhr-80 and acs-2 animals. The data
represents the average results from two independent experiments. The results are expressed as means +/2 SEM (n=6) normalized to the specific
activity of the radioactive palmitate. One-way ANOVA was used to compare with the Neuman-Keuls multiple comparison tests. **,p,0.01,
*** p,0.001.
doi:10.1371/journal.pgen.1002645.g008
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example, Odom et al. performed ChIP on chip to identify
promoters occupied by HNF4a in the human liver and pancreas
and identified 1575 potential HNF4 target genes [35]. In contrast,
gene expression analysis of pancreatic cells in an HNF4a
conditional knockout model identified only 133 genes as HNF4a
regulated [36]. This highlighted that revealing the regulatory
targets and processes of metabolic nuclear receptors needed
further characterization. We therefore performed genome-wide
transcriptional profiling to identify the targets of the PPAR/HNF4
like nuclear receptor NHR-49 in C. elegans. Our analysis revealed a
previously unrecognized role of NHR-49 in the regulation of genes
involved in membrane lipid metabolism, particularly glycosphin-
golipid processing. It will be important to determine whether
mammalian HNF4a also regulates these genes.
It has also been unclear what co-factors of mammalian HNF4a
influence distinct aspects of gene expression. We took advantage of
C. elegans genetics to identify multiple partners of NHR-49 and
confirmed that NHR-66 and NHR-80 physically interact with
NHR-49 using in vitro binding assays. We further characterized the
transcript level changes observed for genes regulated by NHR-66,
NHR-80 and NHR-13. Notably, knockout of nhr-66 affected only
a subset of NHR-49 targets, sphingolipid and lipid remodeling
target genes, whereas knockout of nhr-80 and nhr-13 affected the
expression of NHR-49-regulated fatty acid desaturases. We
therefore propose that NHR-49 and NHR-66 heterodimerize to
regulate genes that mediate the breakdown of glycolipids and
remodeling of lipid membranes, whereas NHR-49 cooperates with
NHR-80 and possibly NHR-13 to sense and regulate the balance
between saturated and unsaturated fat (Figure 9). Even though we
did not detect a direct interaction between NHR-13 and NHR-49,
NHR-13 clearly affects fatty acid desaturation. In the future, it will
be important to determine if the different target genes are direct
NR targets in vivo. To date, it has been difficult to identify a
consensus binding sequence for NHR-49 and other NRs given the
degeneracy of response elements often observed in C. elegans, and
the lack of antibodies suitable for chromatin immunoprecipitation
to define in vivo NR binding sites. GFP reporters of NHR-49/
NHR-66 and NHR-49/NHR-80 regulated genes will be useful to
determine whether these distinct dimers may selectively drive gene
expression in individual tissues. Although HNF4 is not yet known
to dimerize with other partners, it will be critical to determine if
there are similar cofactors and/or it carries out similar mechanistic
roles.
Another interesting finding of this study is the complexity of the
NHR-49 regulatory network. For instance, both NHR-66 and
NHR-80 are NHR-49 co-factors, but there are nuances in their
co- regulation of NHR-49 genes. In the case of NHR-66, the fold
changes observed in sphingolipid and lipid remodeling genes were
comparable to those seen in nhr-49 animals. However, in the case
of NHR-80 and NHR-13, the levels of activation in fatty acid
desaturation regulation did not completely parallel the levels we
observed in nhr-49 mutants. This suggests that additional
regulation of these genes may involve NHR-49 hetero and/or
Figure 9. Model of NHR-49–dependent regulation of lipid metabolism. We propose that NHR-49 (blue) interacts with NHR-66 (pink) to
repress genes involved in sphingolipid processing and lipid remodeling, whereas NHR-49 (blue) binds to NHR-80 (green) to activate the fatty acid
desaturase genes.
doi:10.1371/journal.pgen.1002645.g009
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with our observation that NHR-13 influences NHR-49 regulated
desaturases but may not directly bind to NHR-49. Adding to the
complexity, our gene expression data suggest that, in addition to
the genes jointly regulated by NHR-49/NHR-66 and NHR-49/
NHR-80, NHR-66 and NHR-80 regulate additional genes
independently of NHR-49. In fact, our studies on mitochondrial
morphology and function do not clearly differentiate between the
possibilities that the observed defects are the result of NHR-49-
dependent pathways or the result of multiple independent
pathways regulated by NHR-66 and NHR-80. Our data also
does not exclude the possibility that NHR-66 and NHR-80 act
together for some functions. Future work will be needed to address
these different scenarios and elucidate the complexity of this
transcriptional network.
Influence of NHR-49’s target genes on physiology
Our lifespan analysis revealed that NHR-80 and NHR-13
regulated pathways appear to contribute to the early death of nhr-
49 deletion mutants. We propose that NHR-49’s interaction with
NHR-80 and possibly with NHR-13 modulates the conversion of
saturated to unsaturated fat, and contributes to the shortened
lifespan phenotype of nhr-49 mutants. Supporting this idea, there is
a significant correlation between the C18:0/C18:1n9 ratio and
mean lifespan. This fits well with a recent study that showed the
correlation between several fatty acid metabolic parameters to
longevity, including the ratio of C18 to C18:1n9 [37]. Our data
my also provide insight into the mechanism by which mammalian
HNF4a protects against diabetes. Both in vitro and in vivo studies
showed that pancreatic b-cells are highly susceptible to saturated
fat-induced apoptosis or lipotoxicity [38,39], whereas overexpres-
sion of the fat-6/fat-7 homologue Stearoyl CoA Desaturase (SCD)
protects against this lipotoxicity [40,41]. It is intriguing to
speculate that the shortened lifespan could be related to roles of
HNF4 in protection against premature cell death.
Although NHR-49 is derived from the ancestral HNF4-like
receptors [42], NHR-49 functionally resembles the PPARa. Our
EM data suggest that mitochondrial morphology was abnormal in
nhr-49 mutants, which led us to test mitochondrial function in
these worms. We observed defects in oxygen consumption and
fatty acid b-oxidation, which may be the result of altered
membrane lipids affecting the function of intestinal mitochondria.
Because the co-factor mutants also exhibit mitochondrial defects,
we propose that multiple pathways regulate mitochondrial
function.
It has been shown that PPARs regulate the density (number) of
mitochondria. In fact, PPARc and PPARd promote mitochondrial
biogenesis in a cell-type specific manner, specifically increasing
biogenesis in white adipose tissue and skeletal muscle, respectively
[31,32]. PPARs have also been shown to influence mitochondrial
function by mostly regulating genes encoding mitochondrial fatty
acid b -oxidation enzymes and mitochondrial uncouplers [43].
Our data suggest that nhr-49 mutants differ from wild-type animals
in the shape but not the fractional area (number) of their intestinal
mitochondria. Given that some mitochondria in the nhr-49
mutants are irregular in shape, it would be interesting to determine
if the mitochondria in mammalian PPAR mutant mice exhibit
similar phenotypes. Alternatively, a set of genes not commonly
regulated by NHR-49 and PPAR may contribute to the altered
morphology of the mitochondria in nhr-49 mutants only. In line
with this notion, our study revealed novel NHR-49 dependent
targets and pathways, particularly glycosphingolipid processing
and lipid remodeling, which mammalian PPARs are not known to
regulate.
Insights on evolution of the HNF4 family
When HNF4 and HNF4-like NRs are compared across species
(Table 3), a common theme that emerges is the conservation of
their roles in lipid metabolism pathways. It is possible that one
ancestral role of HNF4–the mobilization of stored energy during
nutrient deprivation and the regulation of b-oxidation–was
adopted by PPARa, whereas other functions of HNF4 were either
retained or outsourced to other NRs. In C. elegans, HNF4-like NRs
underwent a massive expansion and it is likely that various
functions were allocated to different nuclear receptors [44]. HNF4
paralogs in nematodes could then have been selected for divergent
functions that included sphingolipid metabolism and lipid
remodeling.
Mammalian RXR serves as a heterodimer partner for
numerous NRs, including PPARs [45]. We thus speculate that
Table 3. Insights on the evolution of the HNF4 family across species.
Nuclear Receptors Physiological Role Metabolic Pathways Structure Homo Structure Hetero
Mammals
HNF-4a
Liver differentiation, nutrient transport, lipid
metabolism, xenobiotic metabolism, glucose
metabolism, amino acid metabolism, blood
maintenance, immune function
X [56]
PPAR-a/RXR Lipid metabolism, cholesterol metabolism,
glucose metabolism, fasting response
Beta-oxidation, gluconeogenesis X [57]
Drosophila
dHNF-4





Lipid metabolism, xenobiotic metabolism,
fasting response
Beta-oxidation, fatty acid desaturation,
sphingolipid processing, lipid remodeling,
P450, gluconeogenesis
XX
NHR-66 Lipid metabolism Sphingolipid processing, lipid remodeling ? X
NHR-80 Lipid metabolism Fatty acid desaturation ? X
NHR-13 Lipid metabolism Fatty acid desaturation ? X
Yeast
OAF-1/PIP2
Lipid metabolism X [58] X [59]
See text for details.
doi:10.1371/journal.pgen.1002645.t003
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HNF4 roles in mammals. It is possible that NHR-49 hetero-
dimerized with other binding partners to adopt individual tasks
that encompassed the numerous functions of the precursor
nematode HNF4. This is particularly intriguing given the striking
absence of any C. elegans orthologs of RXR-like molecules that in
other organisms heterodimerize with a range of interacting
proteins. NHR-49’s action is promiscuous as it is clearly assuming
different function with different partners. NHR-49 may therefore
serve as an ancestral binding partner reminiscent of the
mammalian RXR. C. elegans thus represents a class of animals
that switched from solely using HNF4 receptors to regulate lipid
metabolism to those that began to employ different heterodimeric
partners to regulate distinct metabolic pathways.
In closing, our study has identified distinct binding partners that
modulate specific pathways of NHR-49 activity. Additionally, we
have also shown that these NRs play a role in mitochondrial
physiology and function. Given the conservation of HNF4
structure, function and regulatory modules across species, it is
possible that mammalian HNF4a utilizes similar mechanisms as
that of C. elegans NHR-49, thus informing us of ways to selectively
modulate its activity. Exploring these possibilities can assist in
pharmacological efforts to manipulate mammalian HNF4a for
specific desired outcomes without any detrimental side-effects.
Materials and Methods
Nematode strains and growth conditions
C. elegans strains N2 Bristol (wild-type), nhr-49(nr2041), nhr-
66(ok940), nhr-80(tm1011), nhr-13(gk796), gas-1(fc21) and acs-
2(ok2457) were grown at 20uC on high-growth plates seeded with
OP50 bacteria and maintained as described [46]. The mutant
strains were obtained from the CGC and were outcrossed at least
five times with wild-type N2 worms. Single-worm PCR was used
to determine the genotype of worms during crossing to generate
nhr-80; nhr-13 and nhr-66; nhr-80 double-mutant lines. For mRNA
and GC/MS analysis, worm embryos were allowed to hatch on
unseeded nematode growth media (NGM)-lite plates overnight at
20uC. The next day, synchronized L1 larvae were plated onto
NGM-lite plates seeded with Escherichia coli strain OP50. Worms
were grown to early L4s at 20uC, harvested, washed three times
with M9, and flash-frozen in liquid N2.
Preparation of total nematode mRNA
C. elegans strains N2-Bristol (wild-type), nhr-49(nr2041), nhr-
66(ok940), nhr-80(tm1011) and nhr-13(gk796) were grown at 20uC
on high-growth plates seeded with OP50 bacteria and maintained
as described [46]. Gravid adults from 10 10-cm plates were
bleached, and embryos were dispersed onto 15-cm nematode
growth media (NGM)-lite plates seeded with OP50. Worms at L4
stage were harvested, washed twice with M9, and frozen in liquid
nitrogen. For RNA preparation, worms were thawed at 65uC for
10 min, and RNA was isolated using the Tri-Reagent Kit
(Molecular Research Center, Cincinnati, Ohio, United States).
Isolated total RNA was subjected to DNAase treatment and
further purification using RNAeasy (Qiagen, Valencia, California).
Yeast two-hybrid screen
For the NHR-49-LBD yeast two-hybrid screen [23], the strain
AH109/pGBK-Leu2-NHR-49-LBD was used to probe a C. elegans
oligo(dT)-primed cDNA library cloned into pPC86 (kindly
provided by the Vidal laboratory, Dana Farber Cancer Institute,
Boston). In short, ,4.3610
6 independent transformants were
screened for growth on medium-stringency plates (lacking
tryptophan, leucine, histidine, and uracil containing 7.5 mM 3-
amino-1,2,4-triazole (3-AT; Sigma, H-8056). Candidate clones
were retested twice for their ability to grow on high-stringency
medium (i.e. medium-stringency plates additionally lacking
adenine), allowing recovery of 141 candidates. Following PCR
and AluI digestion to identify redundant clones, 49 candidate
plasmids were extracted and sequenced, yielding 24 independent
cDNAs of 13 genes (Table S1c). To estimate the relative
interaction strength of these candidate proteins with the NHR-
49-LBD, plasmid pairs were transformed into strain Y187
(Clontech) and liquid b-galactosidase assays were performed as
described in the manufacturer’s protocol.
qRT–PCR and microarray analysis
cDNA was prepared from 5 mg of total RNA in a 100-ml
reaction using the Protoscript cDNA preparation kit (New
England Biolabs, Beverly, Massachusetts, United States). Primer
pairs were diluted into 96-well cell culture plates at a concentration
of 3 mM. Next, 30-ml PCR reactions were prepared in 96-well
plates. Each PCR reaction was carried out with TaqDNA
Polymerase (Invitrogen, Carlsbad, California, United States) and
consisted of the following reaction mixture: 0.3 mM primers, 1/
500th of the cDNA reaction (corresponds to cDNA derived from
10 ng of total RNA), 125 mM dNTPs, 1.5 mM MgCl2, and 16
reaction buffer (20 mM Tris pH 8.4, 50 mM KCl), 0.15 ml (0.75
units) of TaqDNA Polymerase was used for each reaction.
Formation of double-stranded DNA product was monitored using
SYBR-Green (Molecular Probes, Eugene, Oregon, United States).
Data were collected using RNA from at least three independent C.
elegans growths. To determine the relationship between mRNA
abundance and PCR cycle number, all primer sets were calibrated
using serial dilutions of cDNA preparations. qRT-PCR primers
were designed using Primer3 software [47]. qPCR was performed
using a BioRad iCycler (MyiQ Single color).
For microarray analysis, total RNA was assayed for quality
using an UV-Vis spectrophotometer and an Agilent 2100
Bioanalyzer (Agilent Technologies, Inc., Santa Clara, CA). Cy5-
and Cy3-labeled cDNA targets were generated from 30 mg of total
RNA using a reverse transcription, amino-allyl based labeling
protocol [48]. Mutant and wild-type targets were co-hybridized to
Washington University/Genome Sequencing Center C. elegans
23K spotted oligo arrays for 16 hours at 42uC, followed by a series
of stringency washings at 42uC for 5 cycles in 26SSC and 3 cycles
in 0.16SSC using an automated GeneTac Hybridization Station
(Genomic Solutions, Ann Arbor, MI, USA). Post-hybridized
arrays were scanned using a GenePix 4000B scanner (Axon
Instruments, Union City, CA) and image analysis was performed
using GenePix Pro software. Independent datasets were generated
for each mutant vs. wild-type comparison: nhr-49 (n=2, with dye
swap), nhr-66 (n=3), nhr-80 (n=4).
Array data was pre-processed through a custom-built applica-
tion used to filter data based on criteria associated with spot-level
signal quality (e.g., signal-to-noise, lower bound intensity thresh-
old, spot dimension). Each array was background subtracted and
the ratios (mutant/wt) were log2 transformed. Intra-array
normalization was performed using a loess algorithm to correct
for intensity-dependent ratio biasing [49]. For each comparison,
the dataset was filtered by applying a lower-bound signal intensity
cutoff, followed by the application of a variance filter using the
‘shorth’ function in the Bioconductor package genefilter. Pair-wise
significance testing (mutant vs. wild-type) was performed using the
Bioconductor package limma [20] and p-values were initially
corrected for multiple testing using the false discovery rate (FDR)
method of Benjamini and Hochberg [50]. We attempted to define
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5%, however the multiple testing penalty was too high to produce
a gene list in some cases and as such we slightly relaxed our criteria
by employing |log2(ratio)|$0.848 and p-value#0.001.
Gene ontology (GO) enrichment analysis was performed using
GOrilla [21]. Each list from the limma analysis was ranked from
smallest to largest p-value and analyzed for enriched biological
process ontology terms found near the top of the list. Functional
classification summary for the nhr-49 mutant were presented as a
scatter plot using the GO visualization tool REViGO [51].
Fatty acid analysis
Fatty acids were isolated from 10,000 L4 animals grown on a
single 15-cm NGM-Lite plate. Total lipids were extracted and
converted to fatty acid methyl esters (FAMEs) as described [52].
After incubation at 80uC for 1 hour the samples were cooled and
the FAMEs were extracted by adding water and hexane. FAMEs
were analyzed for fatty acid composition by gas chromatography/
mass spectrometry (GC/MS) (Agilent 5975GC, 6920MS). Peaks
were assigned using fatty acid standards.
Plasmids
The PCR products of the full length NHR-49, NHR-66, NHR-
80 and NHR-13 were cloned into the expression vector pCS2
+
that was generously provided by Dr. B. Eisenmann (Fred
Hutchinson Cancer Research Center, Seattle). The PCR product
for NHR-49 was flanked by BamH1/EcoR1, NHR-66 by Stu1/
Xba1, NHR-80 by BamH1/EcoR1 and NHR-13 by BamH1/
EcoR1 and then cloned into the corresponding sites in pCS2
+. For
bacterial expression, GST-NHR-49 was constructed by inserting
BamH1-NHR-49 cDNA-EcoR1 into PGEX-2T vector. All clones
were confirmed by sequence analysis. All plasmid requests should
be directed to Stefan Taubert.
GST–pull down assays
GST-fused to NHR-49 (GST-NHR-49) was induced with
1 mM IPTG for 2 hours at 23uC, expressed in the Escherichia coli
BL21 (DE3) strain and purified using glutathione-Sepharose 4B
beads. The IVTs were transcribed from the SP6 promoter and
translated with the wheat germ system (Promega: Madison, WI), in
the presence of unlabeled (Promega: Madison, WI) or
35S- labeled
methionine (Perkin Elmer) according to the manufacturer’s
instructions. For the in vitro protein-protein interaction assays,
the IVT protein was incubated with GST-NHR-49 for 90 minutes
at 37uC and washed in binding buffer. The samples were then run
on SDS-PAGE and the radiolabeled protein detected by
autoradiography.
Lifespan assays
Approximately 30–40 L1 worms were transferred to 6-cm plates
seeded with L4440 RNAi bacteria and life-span assays were
carried out at 20uC as described previously [53]. The L4 stage was
counted as day 0. Adults were transferred to new plates daily until
progeny production had ceased. Animals were considered dead
when they no longer responded to a gentle tap with a worm pick.
Life span curves and statistical data including p-values from Log-
rank (Mantel-Cox) test were generated using GraphPad Prism
version 5 software (GraphPad Software, San Diego, CA).
High pressure transmission electron microscopy
Day 1 adults were placed into a 20% BSA/PBS buffer solution
and prepared in a Leica-Impact-2 high-pressure freezer. In short,
animals were kept for 60 hours in 100% acetone and uranyl
acetate at 290uC. The temperature was then ramped from
290uCt o225uC over the course of 32.5 hours. Next, samples
were incubated at 225uC for 13 hours. Finally, the temperature
was brought from 225uCt o2 7 uC in a 13 hour temperature ramp.
Serial sections were post-stained in uranyl acetate followed by lead
citrate. Thin cross sections were taken from resin-embedded
clusters of young adults. Sections for adult animals were obtained
from 3 different animals.
Quantification of mitochondria
Ten micron transverse sections typically spanning the length of
the worm from the pharynx to the vulva were examined per
animal. Mitochondria from each section were individually
outlined and the average measurements were obtained using
Image J software. At least two animals were examined per mutant
strain. Statistical data including p-values from unpaired t-tests
using Welch’s correction for unequal variance were generated
using GraphPad Prism version 5 (GraphPad Software). Irregular-
ity in mitochondrial shape was measured by counting the number
of times the mitochondrial outer membrane changed from convex
to concave. A turn was measured every time the mitochondria
changed from convex to concave and vice versa.
Determination of b-oxidation by acid-soluble metabolite
production
The production of acid-soluble metabolites was used as an index
of the b-oxidation of fatty acids based on anassay that was originally
developedfor cell lines [54]. We further modified the protocol for C.
elegans based on the protocol reported by Mullaney et al, 2010 [55].
Synchronized L4 animals were washed off plates with 16 M9
medium and counted. The animals were then rinsed three times in
0.9% NaCl. An aliquot was stored at 280 C for subsequent protein
determination. The worms were resuspended in S-Basal medium
with
14C-palmitic acid (40–60 mCi/mmol) to a final concentration
of 1 mCi /ml complexed to 25% fatty-acid-free BSA (all from GE
Healthcare Life Sciences) per well. Samples were incubated on an
orbital shaker for 2 hours at room temperature. Subsequently, 70%
perchloric acid was added to precipitate the BSA-bound fatty acid.
The samples were centrifuged for 10 minutes at 14,000 g and the
radioactivity of the supernatant was determined by liquid
scintillation. Samples without animals were included as background
controls. These experiments were performed in triplicates two
independent times. Statistical data was analyzed using one-way
ANOVA and p-values were generated using GraphPad Prism
version 5 (GraphPad Software).
Measuring oxygen consumption rates by Seahorse XF-24
analyzer
Between 50 and 100 synchronized L4 worms were washed with
1XM9 and seeded into triplicates of the Seahorse XF-24 cell
culture plates (Seahorse Bioscience, North Billerica, MA) in M9.
Oxygen consumption rates were measured at least five times using
the Seahorse XF-24 Analyzer (Seahorse Bioscience). Measure-
ments were taken under basal conditions and were normalized to
the number of worms counted per well. The Seahorse software
was used to plot the results. The experiment was repeated two
times under these conditions. Statistical data including p-values
from unpaired t-test were generated using GraphPad Prism
version 5 (GraphPad Software).
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